Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and Thymoglobulin for GVHD Prophylaxis in Related Donor HSCT
NCT01246206Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Nov 2010
- Primary completion
- Oct 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by Barbara Ann Karmanos Cancer Institute. Started Nov 2010; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01246206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246206.